Haematological medicines

Haemostasis and clot stability

Haemostasis combines several stages contributing to limitation of bleeding. Coagulation factors and agents affecting fibrinolysis concern different mechanisms. An antifibrinolytic acts on the process of fibrin breakdown rather than being another name for a coagulation factor. Factor concentrates and other antihaemorrhagic agents have particular compositions and indications. Association with blood therefore does not equate these medicines with anticoagulants, whose pharmacological role differs. The distinction is important because similar anatomical terminology can describe products acting on different aspects of clot formation, stability and the wider haemostatic process.

Anaemia and red blood cell production

Anaemia relates to reduced haemoglobin according to the relevant biological criteria and has multiple causes. Iron, vitamin B12 and folic acid preparations have different roles in blood cell production. Other agents concern stimulation of red blood cell production according to their documented indications. Anaemia consequently does not automatically mean iron deficiency. Antianaemic describes several mechanisms rather than a rule matching an isolated laboratory result to a medicinal product. Nutrient identity, biological function and pharmaceutical presentation provide complementary context without establishing the cause of an individual person's anaemia.

Formulations and expressions of content

Iron salts, complexes and other substances have different presentations, oral or parenteral according to the medicine. The amount of a compound and the amount of its active element are not always identical expressions. For coagulation factors, activity units and product characteristics retain their particular documented meaning. Powder with solvent, injectable solution and tablet are not described in the same way. Blood products and other preparations in haematology also retain their specific status: every reference associated with blood does not belong to this one medicine family or share its pharmaceutical scope.

Frequently asked questions